Co-Authors
This is a "connection" page, showing publications co-authored by Alimuddin Zumla and Jean Nachega.
Connection Strength
5.801
-
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S78-S81.
Score: 0.937
-
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S16-S21.
Score: 0.935
-
From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality. Clin Infect Dis. 2021 01 27; 72(2):327-331.
Score: 0.926
-
Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic. N Engl J Med. 2021 Jul 15; 385(3):196-198.
Score: 0.234
-
Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S7-S12.
Score: 0.233
-
Addressing challenges to rolling out COVID-19 vaccines in African countries. Lancet Glob Health. 2021 06; 9(6):e746-e748.
Score: 0.233
-
Contact Tracing and the COVID-19 Response in Africa: Best Practices, Key Challenges, and Lessons Learned from Nigeria, Rwanda, South Africa, and Uganda. Am J Trop Med Hyg. 2021 Feb 11; 104(4):1179-1187.
Score: 0.232
-
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration. Am J Trop Med Hyg. 2020 Dec 28; 104(2):461-465.
Score: 0.230
-
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo. Am J Trop Med Hyg. 2020 12; 103(6):2419-2428.
Score: 0.226
-
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials. Am J Trop Med Hyg. 2020 09; 103(3):960-964.
Score: 0.225
-
The colliding epidemics of COVID-19, Ebola, and measles in the Democratic Republic of the Congo. Lancet Glob Health. 2020 08; 8(8):e991-e992.
Score: 0.222
-
Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo-Priorities for Achieving Control. Am J Trop Med Hyg. 2020 08; 103(2):597-602.
Score: 0.222
-
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings. Am J Trop Med Hyg. 2020 06; 102(6):1184-1188.
Score: 0.221
-
Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer? Am J Trop Med Hyg. 2020 07; 103(1):3-5.
Score: 0.221
-
Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries. Lancet Glob Health. 2020 07; 8(7):e881-e883.
Score: 0.220
-
COVID-19 travel restrictions and the International Health Regulations - Call for an open debate on easing of travel restrictions. Int J Infect Dis. 2020 05; 94:88-90.
Score: 0.219
-
The Critical Need for Pooled Data on Coronavirus Disease 2019 in African Children: An AFREhealth Call for Action Through Multicountry Research Collaboration. Clin Infect Dis. 2021 11 16; 73(10):1913-1919.
Score: 0.061